Therefore, in our case of pilomatricoma detected in a patient with Apert syndrome, we observed the presence of typical genetic mutations of this tumor type, particularly the mutation in the CTNNB1 gene, known to trigger the tumorigenesis process of pilomatricoma through the activation of the WNT signaling pathway. This evidence concerns the gene CTNNB1 and neoplasm.